Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required

• 作者: Amin Talebi Bezmin Abadi
• 来源期刊: 世界胃肠药理与治疗学杂志：英文版（电子版）
• 学科: 医学
• 年，卷（期）: 2017,（4）
• 页码范围: 208-209
• 页数: 2页
• 分类号: R574.4

摘要

Halkj?r et al searched systematically nine articles including 48 patients, and concluded that fecal microbiota transplantation(FMT) can be an ideal treatment option for irritable bowel syndrome(IBS) subjects. Regardless of the few successes in current traditional therapies(change in diet, herbal medicine and antibiotics) in IBS, a sharp increase in interests in the FMT option has been reported in the current century. However, there is a long list of unclear issues concerning the application of FMT for the treatment of IBS. Route of delivery and optimum dosage are the major concerns to consider before using in clinical practice.